Cipla To Hold Off On Pediatric Cancer Drug Generic Until 2033
By Elliot Weld · March 17, 2026, 3:45 PM EDT
Specialty drugmaker Fennec Pharmaceuticals has jointly announced with Indian multinational pharmaceutical company Cipla Ltd. that they had reached an agreement to settle patent infringement litigation in exchange for Cipla delaying the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login